(2Z)-4-(3,4-DICHLOROPHENYL)-2-((5-HYDROXY-2-(4-METHYL-1-PIPERAZINYL)PHENYL)METHYLENE)-3-THIOMORPHOLINONE
UNII DMT4KZK6LQ
Substance Identification & Data
This profile provides standardized clinical and technical data for (2z)-4-(3,4-dichlorophenyl)-2-((5-hydroxy-2-(4-methyl-1-piperazinyl)phenyl)methylene)-3-thiomorpholinone, uniquely identified by the FDA Unique Ingredient Identifier (UNII) DMT4KZK6LQ.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1809096-97-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C22H23Cl2N3O2S PCICWUSZYZLXID-BKUYFWCQSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (2z)-4-(3,4-dichlorophenyl)-2-((5-hydroxy-2-(4-methyl-1-piperazinyl)phenyl)methylene)-3-thiomorpholinone. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.